SBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.
| Revenue (TTM) | $175.17M |
| Gross Profit (TTM) | $125.86M |
| EBITDA | $68.63M |
| Operating Margin | 38.60% |
| Return on Equity | 18.90% |
| Return on Assets | 11.30% |
| Revenue/Share (TTM) | $1.71 |
| Book Value | $2.57 |
| Price-to-Book | 1.89 |
| Price-to-Sales (TTM) | 2.88 |
| EV/Revenue | 2.069 |
| EV/EBITDA | 4.58 |
| Quarterly Earnings Growth (YoY) | 338.90% |
| Quarterly Revenue Growth (YoY) | 13.40% |
| Shares Outstanding | $102.85M |
| Float | $18.11M |
| % Insiders | 81.53% |
| % Institutions | 4.41% |
Volatility is currently contracting
IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in October 2026.
Irvine, California--(Newsfile Corp. - September 10, 2026) - SBC Medical Group Holdings Incorporated (NASDAQ: SBC) ("The Company" or "SBC Medical"), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in the upcoming 3 rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel. Hikaru Fukui, Head of IR department of SBC Medical, will be presenting on the company's recent milestones and future growth strategy.
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical will be conducting a Non-Deal Roadshow (NDR) and participating in several investor conferences throughout September 2026.
NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research quarterly update on SBC Medical Group Holdings Incorporated (NASDAQ:SBC), which, together with its subsidiaries, provides management services to cosmetic treatment centers via a franchise model in Japan, Vietnam, Thailand, Singapore, and the United States. This release is being issued as an updated version of EGR's previously published press release regarding its Q2:26 Quarterly Update on SBC Medical Group Holdings Incorporated.
NEW YORK CITY, NY / ACCESS Newswire / August 24, 2026 / Emerging Growth Research today announced the release of its Q2:26 Quarterly Update Report on SBC Medical Group Holdings (NASDAQ:SBC), reiterating its Buy rating and increasing its 12-month price target to $11.00 from $10.00. The Quarterly Update highlights SBC Medical Group's return to revenue growth in 2026 following the completion of pricing-related headwinds experienced during 2025, while emphasizing the Company's strong cash position, expanding clinic footprint, continued international expansion, and new AI-driven growth initiatives.
SBC Medical Group NASDAQ: SBC said its growth re-accelerated in the second quarter of 2026 as the company completed structural reforms undertaken in 2025, expanded its clinic network and increased management-services revenue.
SBC Medical Group NASDAQ: SBC said its second-quarter 2026 results reflected a reacceleration in growth following structural reforms undertaken in 2025, with adjusted EBITDA rising faster than revenue despite the effect of a weaker yen on reported results.
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year.
IRVINE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the second quarter ended June 30, 2026, before U.S. market open on August 13, 2026.
IRVINE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced that Stephen Rodgers, Head of Global Planning and Strategy, and Hikaru Fukui, Head of IR Department, have been invited to present at “Health, Wellness & Longevity,” presented by Maxim Group LLC, on Wednesday, July 22nd at 10:30 a.m.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SBC and any ticker you trade — then tracks every position and per-strategy win rate.
